🇺🇸 FDA
Patent

US 10946000

Method for treating cancer with combination therapy

granted A61KA61K31/435A61K31/438

Quick answer

US patent 10946000 (Method for treating cancer with combination therapy) held by RedHill Biopharma Ltd. expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RedHill Biopharma Ltd.
Grant date
Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/435, A61K31/438, A61K31/4409, A61K31/495